Feed RCE.AX
RC
Recce Pharmaceuticals Ltd
RCE.AX · ASX
$0.37 -1.33% (-$0.01)
1M -2.60%
Market Cap $114.7M
P/E Ratio -
Div. Yield -
ROE -
Valuation
0 /100
Expensive P/S 15.27x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 34.52%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 285.37%
Op. margin 304.71%
FCF margin 272.59%
Quality
11 /100
Poor ROA 172.61%
Asset turnover 0.60x
ROIC 195.20%
Debt
40 /100
Moderate Int. coverage -16.19x
Current ratio 1.86x
Net debt/EBITDA N/A
Stability
56 /100
Moderate Rev. volatility 17.88%
EPS volatility 22.01%
Profitable years 0
Întreabă StockBot despre RCE.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James Hamilton-Bray Graham
Employees
8
Headquarters
Sydney
Evenimente viitoare
28 AUG.
Earnings
Upcoming earnings report